Importance of age of onset in pancreatic cancer kindreds

Journal of the National Cancer Institute

Volumn 102, Issue 2, 2010, Pages 119-126

  Brune, Kieran A ^a   Lau, Bryan ^a,b   Palmisano, Emily ^a   Canto, Marcia ^a   Goggins, Michael G ^a   Hruban, Ralph H ^a   Klein, Alison P ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PANCREAS CANCER; PRIORITY JOURNAL; RELATIVE; RISK ASSESSMENT; RISK FACTOR; STANDARDIZED INCIDENCE RATIO; UNITED STATES;

ADULT; AGE OF ONSET; AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; PANCREATIC NEOPLASMS; SEER PROGRAM; UNITED STATES;

EID: 75149143956     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp466     Document Type: Article

References (45)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009; 59 (4): 225-249.
2. Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008; 321 (5897): 1801-1806.
3. Fuchs CS, Colditz GA, Stampfer MJ, et al. A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med. 1996; 156 (19): 2255-2260.
4. Coughlin SS, Calle EE, Patel AV, Thun MJ. Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control. 2000; 11 (10): 915-923.
5. Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg. 2008; 393 (4): 535-545.
6. Berrington de GA, Sweetland S, Spencer E. A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer. 2003; 89 (3): 519-523.
7. Michaud DS, Giovannucci E, Willett WC, Colditz GA, Stampfer MJ, Fuchs CS. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA. 2001; 286 (8): 921-929.
8. Ghadirian P, Boyle P, Simard A, Baillargeon J, Maisonneuve P, Perret C. Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol. 1991; 10 (3-4): 183-196.
9. Silverman DT. Risk factors for pancreatic cancer: a case-control study based on direct interviews. Teratog Carcinog Mutagen. 2001; 21 (1): 7-25.
10. Klein AP, Hruban RH, Brune KA, Petersen GM, Goggins M. Familial pancreatic cancer. Cancer J. 2001; 7 (4): 266-273.
11. Hemminki K, Li X. Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden. Int J Cancer. 2003; 103 (4): 525-530. (Pubitemid 36020229)
12. Klein AP, Brune KA, Petersen GM, et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res. 2004; 64 (7): 2634-2638.
13. Tersmette AC, Petersen GM, Offerhaus GJ, et al. Increased risk of incident pancreatic cancer among fi rst-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res. 2001; 7 (3): 738-744.
14. Couch FJ, Johnson MR, Rabe KG, et al. The prevalence of BRCA2 mutations in familial pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16 (2): 342-346.
15. Goggins M, Schutte M, Lu J, et al. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res. 1996; 56 (23): 5360-5364.
16. Su GH, Hruban RH, Bansal RK, et al. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol. 1999; 154 (6): 1835-1840.
17. Goldstein AM, Fraser MC, Struewing JP, et al. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med. 1995; 333 (15): 970-974.
18. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene [see comments]. Nat Genet. 1996; 14 (2): 141-145.
19. Jones S, Hruban RH, Kamiyama M, et al. Exomic sequencing identifi es PALB2 as a pancreatic cancer susceptibility gene. Science. 2009; 324 (5924): 217.
20. Klein AP, Beaty TH, Bailey-Wilson JE, Brune KA, Hruban RH, Petersen GM. Evidence for a major gene infl uencing risk of pancreatic cancer. Genet Epidemiol. 2002; 23 (2): 133-149.
21. Petersen G, de Andrade M, Goggins M, et al. Pancreatic Cancer Genetic Epidemiology (PACGENE) Consortium. Cancer Epidemiol Biomarkers Prev. 2006; 15 (4): 704-710.
22. James TA, Sheldon DG, Rajput A, et al. Risk factors associated with earlier age of onset in familial pancreatic carcinoma. Cancer. 2004; 101 (12): 2722-2726.
23. Lynch HT, Boland CR, Rodriguez-Bigas MA, Amos C, Lynch JF, Lynch PM. Who should be sent for genetic testing in hereditary colorectal cancer syndromes? J Clin Oncol. 2007; 25 (23): 3534-3542.
24. Claus EB, Risch NJ, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol. 1990; 131 (6): 961-972.
25. Bartsch DK, Kress R, Sina-Frey M, et al. Prevalence of familial pancreatic cancer in Germany. Int J Cancer. 2004; 110 (6): 902-906.
26. Surveillance EaERP. SEER*Stat Database: Incidence SEER 9 Regs, November 2002 submission (1973-2000). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2003, based on the November 2002 submission; 2003.
27. Rothman KJ, Boice JD. Epidemiologic Analysis With a Programmable Calculator. Washington, DC: US Government Printing Offi ce. NIH publication 79-1649; 1979.
28. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol.2. Lyon, France: World Health Organization: IARC; 1987: 68-71.
29. Andea A, Sarkar F, Adsay VN. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mod Pathol. 2003; 16 (10): 996-1006.
30. Kalbfl eisch JD. The Statistical Analysis of Failure Time Data. New York, NY: Wiley 1980.
31. Andersen PK. Statistical Models Based upon Counting Processes. New York, NY: Springer-Verlag; 1993.
32. Cheng SC, Fine JP, Wei LJ. Prediction of cumulative incidence function under the proportional hazards model. Biometrics. 1998; 54 (1): 219-228.
33. Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol. 2009; 170 (2): 244-256.
34. Prentice RL, Kalbfl eisch JD, Peterson AV Jr, Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics. 1978; 34 (4): 541-554.
35. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics. 1995; 51 (2): 524-532.
36. Beyersmann J, Dettenkofer M, Bertz H, Schumacher M. A competing risks analysis of bloodstream infection after stem-cell transplantation using subdistribution hazards and cause-specifi c hazards. Stat Med. 2007; 26 (30): 5360-5369.
37. Beyersmann J, Schumacher M. Misspecifi ed regression model for the subdistribution hazard of a competing risk. Stat Med. 2007; 26 (7): 1649-1651.
38. Lipsitz SR, Parzen M. A jackknife estimator of variance for Cox regression for correlated survival data. Biometrics. 1996; 52 (1): 291-298.
39. Royston P, Altman DG. Regression using fractional polynomial of continuous covariates: parsimonious parametric modeling. Appl Stat. 1994; 43: 429-467.
40. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol. 1999; 28 (5): 964-974.
41. Efron B. The jackknife, the bootstrap and other resampling plans. Philadelphia, PA: Society for the Industrial and Applied Mathematics; 1982.
42. Canto M, Goggins M, Hruban R, et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol. 2006; 4 (6): 776-781.
43. Canto MI, Goggins M, Yeo CJ, et al. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol. 2004; 2 (7): 606-621.
44. Wang W, Chen S, Brune KA, Hruban RH, Parmigiani G, Klein AP. PancPRO: risk assessment for individuals with a family history of pancreatic cancer. J Clin Oncol. 2007; 25 (11): 1417-1422.
45. Gilpin EA, Pierce JP, Cavin SW, et al. Estimates of population smoking prevalence: self-vs proxy reports of smoking status. Am J Public Health. 1994; 84 (10): 1576-1579.